Key features
Thematically oriented, concentrated approach to portfolio management
Focused on competitively advantaged companies well positioned to participate in major demand trends
Dedicated investment team has utilized the same investment philosophy since 1997
Daily pricing
as of
09/21/2020
NAV 1-day net change
No Change
Total net assets
as of
08/31/2020
All share classes
$3.4 billion
Overview
| Fund identifiers |
|---|
| NASDAQ | DFDIX |
| CUSIP | 245906201 |
Benchmark and peer group
Portfolio
Market cap (median) Source: FactSet
$10.7 billion
Market cap (weighted average) Source: FactSet
$12.3 billion
Portfolio turnover (last fiscal year)
113%
Cash and cash equivalents
0.1%
Top 10 holdings
as of 08/31/2020
Holdings are as of the date indicated and subject to change.
List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Fund's complete list of holdings for more information.
Holdings based by issuer.
iRhythm Technologies Inc.
4.35
Pacira Pharmaceuticals Inc.
4.15
Total % Portfolio in Top 10 holdings - 38.85%
Sector allocation
as of 08/31/2020
List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Fund’s complete list of holdings for more information.
Information technology
28.9%
Consumer discretionary
20.7%
Communication services
8.8%
Distribution history - annual distributions (Institutional Class)1,2
Distributions ($ per share)
1If a Fund makes a distribution from any source other than net income, it is required to provide shareholders with a notice disclosing the source of such distribution (each a "Notice"). The amounts and sources of distributions reported above and in each Notice are only estimates and are not provided for tax reporting purposes. Each Fund will send each shareholder a Form 1099 DIV for the calendar year that will provide definitive information on how to report the Fund's distributions for federal income tax purposes. The information in the table above will not be updated to reflect any subsequent recharacterization of dividends and distributions. Click here to see recent Notices pertaining to the Fund (if any).
2Information on return of capital distributions (if any) is only provided from June 1, 2014 onward.
3Includes both short- and long-term capital gains.
Management
Alex Ely
-
Managing Director, Chief Investment Officer — US Growth Equity
-
Start date on the Fund:
July 2016
-
Years of industry experience:
28
-
Read bio
Alex Ely
Managing Director, Chief Investment Officer — US Growth Equity
Alex Ely joined Macquarie Investment Management (MIM) in February 2016 as part of the firm’s acquisition of Bennett Lawrence Management, LLC, a New York–based US growth equity manager. Prior to joining the firm as CIO of the US Growth Equity team, he was portfolio manager and chief portfolio strategist at Bennett Lawrence. Ely joined Bennett Lawrence in 1997 as a portfolio analyst, and in 2002 he was promoted to portfolio manager. Before joining Bennett Lawrence, he was an equity product manager at Oppenheimer Management. From 1988 to 1989, he was a strategy clerk at the Boston Stock Exchange. Ely earned a bachelor’s degree in economics from the University of New Hampshire.
Fees
The table below describes the fees and expenses that you may pay if you buy and hold shares of the Fund.
| Shareholder fees |
|---|
| Maximum sales charge (load) imposed on purchases as a percentage of offering price | none |
| Maximum contingent deferred sales charge (load) as a percentage of original purchase price or redemption price, whichever is lower | none |
| Annual fund operating expenses |
|---|
| Management fees | 0.69% |
| Distribution and service (12b-1) fees | none |
| Other expenses | 0.16% |
| Total annual fund operating expenses | 0.85% |
| Fee waivers and expense reimbursements | none |
| Total annual fund operating expenses after fee waivers and expense reimbursements | 0.85% |
Resources
Fact sheet and commentaries
Institutional Class shares are available only to certain investors. See the prospectus for more information.
You are now leaving the Delaware Funds by Macquarie website
The link you have selected will take you to a website not controlled by Delaware Funds by Macquarie. Your web browser will automatically redirect you to the site in a few moments. Delaware Funds by Macquarie is not responsible for the content of the website you are about to visit.
Thank you for visiting the Delaware Funds by Macquarie website.
Other than Macquarie Bank Limited (MBL), none of the entities noted are authorised deposit-taking institutions for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these entities do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of these entities, unless noted otherwise.
The Funds are distributed by Delaware Distributors, L.P., an affiliate of Macquarie Investment Management Business Trust (MIMBT), Macquarie Management Holdings, Inc., and Macquarie Group Limited. Macquarie Investment Management (MIM), a member of Macquarie Group, refers to the companies comprising the asset management division of Macquarie Group Limited and its subsidiaries and affiliates worldwide.
Separately managed account advisory services are provided by Delaware Capital Management (DCM), a series of MIMBT. Separately managed account advisory services are referred through Delaware Capital Management Advisers, Inc., an SEC-registered investment advisor.